•     Contact us  Chinese
    Shanghai Newsummit Biopharma Co.Ltd
    business solutions
    core business

    Core Business Model

    Key Products

    core competitive advantages

    Core Competitive Advantages
    & Industry Status

    Newsummit CRO Service Network

    company profile

    We are a leading China-based new drug development process solutions provider. Our main business is to provide professional technology service for new drug research and development. Through collabo-ration with five state high tech clusters and integration of upstream and downstream suppliers, we establish the Platform of Chain R&D (PCRD) by offering a full range of services for new drug R&D.

    We set up a modularized, standardized and industrialized pipeline system to provide Good Research and Development Practices (GRDP) for new drug R&D, including: pre-clinical new drug research service focusing on pharmacology and toxicology research (IND-CRO);phase I, II and III clinical studies and pilot-scale up studies (NDA-CRO); international multi-center clinical research service and international clinical Phase I/II studies after completing SFDA II A clinical studies(FDA/EMEA-CRO); research and registration services on medical devices, diagnostics, medical equipment; during their new drug development process, our value-added services will provide clients with opportunities to access additional funding, such as government research grants and private investment......

    ·  Shanghai Newsummit Biopharma Successfully Held "Scientific Action ...
    ·  The IND Sumbission of of Biological New Drug (Category I)"ZD55-IL-...
    ·  The Inauguration of National Science and Technology Enterprise Inc...
    ·  Warm Congratulations to Wuhan Biolake New Drug Incubation Public S...
    ·  China Torch Program-PCRD platform passed the acceptance test...
    Address: 2F,No.780,Cailun Road,Zhangjiang High Technology Park,Shanghai City,China
    Tel: +86-21-50798788-8032
    Fax: +86-21-50798788-8088
    Website: http://www.www.bjfryy.cn/
    Email: ibd_information@www.bjfryy.cn

    U.S. bio

    Copyright(C)2016,Shanghai Newsummit Biopharma Co.Ltd All Rights Reserved.  Supported by Information Center